136 related articles for article (PubMed ID: 11269881)
41. Clinical characteristics and genetic screening of an extended family with MEN2A.
Algün E; Abaci N; Kösem M; Kotan C; Köseoğlu B; Boztepe H; Sekeroğlu R; Aslan H; Topal C; Ayakta H; Uygan I; Alagöl F; Erginel-Unaltuna N; Aksoy H
J Endocrinol Invest; 2002; 25(7):603-8. PubMed ID: 12150334
[TBL] [Abstract][Full Text] [Related]
42. Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?
Rone JK; Lane AG; Grinkemeyer MD
Thyroid; 1998 Sep; 8(9):781-5. PubMed ID: 9777749
[TBL] [Abstract][Full Text] [Related]
43. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
Acton DS; Velthuyzen D; Lips CJ; Höppener JW
Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
[TBL] [Abstract][Full Text] [Related]
44. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
[TBL] [Abstract][Full Text] [Related]
45. Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.
Uchino S; Noguchi S; Yamashita H; Sato M; Adachi M; Yamashita H; Watanabe S; Ohshima A; Mitsuyama S; Iwashita T; Takahashi M
Jpn J Cancer Res; 1999 Nov; 90(11):1231-7. PubMed ID: 10622534
[TBL] [Abstract][Full Text] [Related]
46. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
[TBL] [Abstract][Full Text] [Related]
47. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
Marsh DJ; McDowall D; Hyland VJ; Andrew SD; Schnitzler M; Gaskin EL; Nevell DF; Diamond T; Delbridge L; Clifton-Bligh P; Robinson BG
Clin Endocrinol (Oxf); 1996 Feb; 44(2):213-20. PubMed ID: 8849577
[TBL] [Abstract][Full Text] [Related]
48. Incidental detection of familial medullary thyroid carcinoma by calcitonin screening for nodular thyroid disease.
Mayr B; Brabant G; von zur Mühlen A
Eur J Endocrinol; 1999 Sep; 141(3):286-9. PubMed ID: 10474127
[TBL] [Abstract][Full Text] [Related]
49. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
50. A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys-->Arg).
Nakao A; Naomoto Y; Kataoka M; Haisa M; Kataoka K; Saitoh S; Fujiwara T; Yamatsuji T; Shigemitsu K; Umeoka T; Isozaki H; Futami H; Yamaguchi K; Tanaka N
Jpn J Clin Oncol; 2001 Apr; 31(4):157-61. PubMed ID: 11386462
[TBL] [Abstract][Full Text] [Related]
51. Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas.
Scurini C; Quadro L; Fattoruso O; Verga U; Libroia A; Lupoli G; Cascone E; Marzano L; Paracchi S; Busnardo B; Girelli ME; Bellastella A; Colantuoni V
Mol Cell Endocrinol; 1998 Feb; 137(1):51-7. PubMed ID: 9607728
[TBL] [Abstract][Full Text] [Related]
52. Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain.
Bugalho MJ; Frade JP; Santos JR; Limbert E; Sobrinho L
Eur J Endocrinol; 1997 Apr; 136(4):423-6. PubMed ID: 9150704
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
Allen SM; Bodenner D; Suen JY; Richter GT
Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
[TBL] [Abstract][Full Text] [Related]
54. [The RET gene in thyroid pathology].
Michiels FM; Billaud M
Arch Anat Cytol Pathol; 1998; 46(1-2):19-30. PubMed ID: 9754357
[TBL] [Abstract][Full Text] [Related]
55. Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature.
Kebebew E; Tresler PA; Siperstein AE; Duh QY; Clark OH
Thyroid; 1999 Feb; 9(2):127-31. PubMed ID: 10090311
[TBL] [Abstract][Full Text] [Related]
56. A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation.
Miyauchi A; Egawa S; Futami H; Kuma K; Obara T; Yamaguchi K
Jpn J Cancer Res; 1997 Jun; 88(6):527-31. PubMed ID: 9263528
[TBL] [Abstract][Full Text] [Related]
57. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA
Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675
[TBL] [Abstract][Full Text] [Related]
58. [Proto-oncogene RET somatic mutations in medullary thyroid carcinoma].
Wiench M; Kwaśniewski M; Gubała E; Wygoda Z; Pawlaczek A; Oczko M; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():415-21. PubMed ID: 12182058
[TBL] [Abstract][Full Text] [Related]
59. Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma.
Koch CA; Huang SC; Moley JF; Azumi N; Chrousos GP; Gagel RF; Zhuang Z; Pacak K; Vortmeyer AO
Oncogene; 2001 Nov; 20(53):7809-11. PubMed ID: 11753660
[TBL] [Abstract][Full Text] [Related]
60. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
